Page last updated: 2024-08-25

zoledronic acid and Orphan Diseases

zoledronic acid has been researched along with Orphan Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asha, HS; Cherian, KE; Paul, TV; Rajan, R1
Bezaury, AP; Nevarez-Barragan, MJ; Perez-Diaz, I; Rosas-Jurado, MG; Trejo-Rosales, R1
Gehlen, M; Hinz, C; Lazarescu, AD; Maier, A; Pfeifer, M; Schmidt, N; Schwarz-Eywill, M; Weidemann, HF; Werner, M1

Other Studies

3 other study(ies) available for zoledronic acid and Orphan Diseases

ArticleYear
McCune Albright syndrome: an endocrine medley.
    BMJ case reports, 2019, Jul-15, Volume: 12, Issue:7

    Topics: Adenoma; Bone Density Conservation Agents; Cabergoline; Diagnosis, Differential; Dopamine Agonists; Female; Fibrous Dysplasia, Polyostotic; Humans; Hyperthyroidism; Leg; Musculoskeletal Pain; Pituitary Neoplasms; Rare Diseases; Young Adult; Zoledronic Acid

2019
Rare association between penile squamous cell carcinoma and parathyroid related peptide (PTH-rP) secretion.
    Arquivos brasileiros de endocrinologia e metabologia, 2014, Volume: 58, Issue:6

    Topics: Bone Density Conservation Agents; Carcinoma, Squamous Cell; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Parathyroid Hormone; Pelvis; Penile Neoplasms; Rare Diseases; Tomography, X-Ray Computed; Zoledronic Acid

2014
[Severe therapy refractive osteoporosis : A rare differential diagnosis].
    Zeitschrift fur Rheumatologie, 2016, Volume: 75, Issue:7

    Topics: Adult; Anti-Inflammatory Agents; Bone Density Conservation Agents; Chronic Disease; Diagnosis, Differential; Diphosphonates; Female; Humans; Imidazoles; Male; Mastocytosis, Systemic; Middle Aged; Osteoporosis; Rare Diseases; Treatment Failure; Treatment Outcome; Zoledronic Acid

2016